Xylazine: “Zombie Drug” is an Emerging Threat
ACEP Now
JULY 7, 2023
CASE A 30-year-old woman presents to the emergency department with left arm pain from a chronic wound. Initial stabilization includes airway management and circulatory support. Currently, there is no FDA-approved pharmacotherapy for either the reversal of xylazine in humans or the management of withdrawal.
Let's personalize your content